Novacyt (LSE:NCYT) Cash Flow for Dividends: £0.00 Mil (TTM As of Dec. 2025)


LSE:NCYT Novacyt SA LSE:NCYT
38 GF Score
Price £0.35
GF Value £0.72
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Novacyt Cash Flow for Dividends?

Novacyt LSE:NCYT 38 Cash Flow for Dividends is £0.00 Mil as of Dec. 2025. GuruFocus rates LSE:NCYT with a GF Score™ of 38/100 and a GF Value™ of £0.72 (Possible Value Trap). The stock has 4 warning signs investors should review.

Novacyt's cash flow for dividends for the six months ended in Dec. 2025 was £0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was £0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Novacyt Cash Flow for Dividends Related Terms

Novacyt Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Novacyt's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novacyt Cash Flow for Dividends Chart

Novacyt Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Novacyt Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:NCYT
38GF Score
Novacyt SA LSE:NCYT
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novacyt Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of £0.00 Mil mean?
Novacyt (LSE:NCYT) has a Cash Flow for Dividends of £0.00 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Novacyt and its competitors.
Is Novacyt's Cash Flow for Dividends too high?
Novacyt's current Cash Flow for Dividends is £0.00 Mil. Overall, Novacyt has a GF Score™ of 38/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Novacyt's Cash Flow for Dividends compare to ABT and SYK?
Novacyt's Cash Flow for Dividends of £0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Novacyt and its competitors. Novacyt's current Cash Flow for Dividends is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novacyt stock overvalued right now?
Based on GuruFocus' analysis, Novacyt (LSE:NCYT) is currently considered Possible Value Trap. The stock's GF Value™ is £0.72, compared to a current price of £0.35 — trading 52.1% below its estimated fair value. The current Cash Flow for Dividends is £0.00 Mil. Novacyt's overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Novacyt (LSE:NCYT), the current Cash Flow for Dividends is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novacyt (LSE:NCYT) Overvalued in 2026?

Based on GuruFocus' analysis, Novacyt stock appears to be undervalued. The current stock price of £0.35 is trading 52.1% below its estimated GF Value™ of £0.72. GuruFocus considers Novacyt to be Possible Value Trap.

Key valuation signals for LSE:NCYT:

  • Cash Flow for Dividends: £0.00 Mil
  • GF Value™: £0.72 vs. price of £0.35 (52.1% below fair value)
  • GF Score™: 38/100 with 4 warning signs

No single metric tells the full story. See the LSE:NCYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novacyt Business Description

Address 131 Boulevard Carnot, Le Vesinet, FRA, 78110
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, Yourgene Health and Corporate. Majority of the revenue is generated from Yourgene Health segment. Geographically, the company operates in United Kingdom, France, Europe, America, Asia-Pacific, Middle East and Africa generating majority from Asia- pacific region.
38GF Score

Get the complete analysis for LSE:NCYT

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.35
Price
£0.72
GF Value